Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Sodium valproate reduced seizures in many patients with resistant epilepsy.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Researchers found a new sign of fungal infection in some patients with Seborrheic Dermatitis.

People with trichotillomania or skin picking disorder generally sleep worse than those without these conditions.

Increasing olanzapine caused hair loss in a woman, which stopped after changing medication.

Men use cosmetic surgery to feel and look better, often influenced by traditional masculinity ideals.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

Kids with skin problems are more likely to have mental health issues.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Sertraline, an antidepressant, may rarely cause hair loss.

Mood stabilizers for bipolar disorder can cause skin issues, but severe reactions are rare.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

A man developed a rare late-onset hair-pulling disorder, usually seen in younger people.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Gunshot injuries to the face require urgent care and multiple surgeries for recovery.

Eating disorders in gender dysphoria patients may be a coping mechanism for body image issues.

UVA-1 phototherapy might help treat alopecia areata.

Precision neuromodulation may improve schizophrenia symptoms.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.